Eliem Therapeutics shares owned by Summit Investment Advisors
Quarter-by-quarter ownership of Eliem Therapeutics (CLYM) shares owned by Summit Investment Advisors
from 13F filings
Historical chart of Summit Investment Advisors investment in Eliem Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Eliem Therapeutics held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Eliem Therapeutics by Summit Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $42k | 3.2k | 13.04 |
| 2025-03-31 | $3.6k | 3.0k | 1.22 |
| 2024-12-31 | $5.4k | 3.0k | 1.80 |
| 2024-09-30 | $15k | 3.0k | 5.09 |
| 2024-06-30 | $5.1k | 714 | 7.11 |
| 2022-03-31 | $5.0k | 541 | 9.24 |
| 2021-12-31 | $6.0k | 541 | 11.09 |
| 2021-09-30 | $10k | 541 | 18.48 |
More positions owned by Summit Investment Advisors
View all positions for Summit Investment Advisors